Erscheinungsjahr
Format
Lizenz
Sprache
-
Zoledronic acid for the treatment of prostate cancer
Taylor & Francis Verlag | 2019|Schlagwörter: Metastatic castration-resistant prostate cancer -
Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report
Freier ZugriffKarger Verlag | 2021|Schlagwörter: Metastatic castration-resistant prostate cancer -
Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital
Wiley | 2018|Schlagwörter: metastatic castration‐resistant prostate cancer -
Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer
Taylor & Francis Verlag | 2021|Schlagwörter: metastatic castration-resistant prostate cancer -
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents
Online Contents | 2021|Schlagwörter: Metastatic castration-resistant prostate cancer -
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis
Wiley | 2023|Schlagwörter: non‐metastatic castration‐resistant prostate cancer, metastatic castration‐resistant prostate cancer -
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer
Freier ZugriffOnline Contents | 2016|Schlagwörter: Metastatic castration-resistant prostate cancer -
Phenotypic diversity of circulating tumour cells in patients with metastatic castration‐resistant prostate cancer
Wiley | 2017|Schlagwörter: metastatic castration‐resistant prostate cancer -
Combination of body mass index and albumin predicts the survival in metastatic castration‐resistant prostate cancer patients treated with abiraterone: A post hoc analysis of two randomized trials
Freier ZugriffWiley | 2021|Schlagwörter: metastatic castration‐resistant prostate cancer -
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Freier ZugriffOnline Contents | 2020|Schlagwörter: Non-metastatic castration-resistant prostate cancer -
Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients
Wiley | 2018|Schlagwörter: metastatic castration‐resistant prostate cancer -
Taxane chemotherapy vs antiandrogen agents as first‐line therapy for metastatic castration‐resistant prostate cancer
Wiley | 2018|Schlagwörter: metastatic castration‐resistant prostate cancer -
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer
Online Contents | 2019|Schlagwörter: Metastatic castration-resistant prostate cancer -
Protein kinase inhibitors for the treatment of prostate cancer
Taylor & Francis Verlag | 2021|Schlagwörter: metastatic castration-resistant prostate cancer -
No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer
Online Contents | 2017|Schlagwörter: Metastatic castration-resistant prostate cancer -
Non-metastatic castration-resistant prostate cancer: current status and future directions
Taylor & Francis Verlag | 2020|Schlagwörter: Non-metastatic castration-resistant prostate cancer -
Clinical outcomes and survival surrogacy studies of prostate‐specific antigen declines following enzalutamide in men with metastatic castration‐resistant prostate cancer previously treated with docetaxel
Wiley | 2017|Schlagwörter: metastatic castration‐resistant prostate cancer -
Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration‐resistant prostate cancer
Freier ZugriffWiley | 2016|Schlagwörter: Metastatic castration resistant prostate cancer -
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer
Freier ZugriffOnline Contents | 2019|Schlagwörter: Metastatic castration-resistant prostate cancer -
The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer
Freier ZugriffWiley | 2022|Schlagwörter: metastatic castration‐resistant prostate cancer
Meine Suche schicken an (beta)
Schicken Sie ihre Suchanfrage (Suchterm ohne Filter) an andere Datenbanken, Portale und Kataloge, um ggf. weitere interessante Treffer zu finden:
Dimensions ist eine Datenbank für Abstracts und Zitate, die Informationen zu Forschungsförderungen mit daraus resultierenden Veröffentlichungen, Studien und Patenten verknüpft.
Im TIB AV-Portal können audiovisuelle Medien aus Wissenschaft und Lehre recherchiert und eigene wissenschaftliche Videos publiziert werden.
Im FID move kann nach fachspezifischer Literatur, Forschungsdaten und weitere Informationen aus der Mobilitäts- und Verkehrsforschung gesucht werden.
Der Open Research Knowledge Graph liefert strukturiert beschriebene Forschungsinhalte und macht diese vergleichbar.
Frei zugänglicher Ausschnitt der Verbunddatenbank K10plus des GBV und des SWB mit für die Fernleihe und Direktlieferdienste relevanten Materialien.